Phase I study of docetaxel plus ifosfamide in patients with advanced cancer

MLA

Stephen P. Ackland, et al. “Phase I Study of Docetaxel plus Ifosfamide in Patients with Advanced Cancer.” British Journal of Cancer, vol. 87, no. 8, Mar. 2002. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....05aef2b51d5f33a94acc3f3228290c0e&authtype=sso&custid=ns315887.

APA

Stephen P. Ackland, Gavin Marx, C. R. Lewis, John A. Levi, & K Hall. (2002). Phase I study of docetaxel plus ifosfamide in patients with advanced cancer. British Journal of Cancer, 87(8).

Chicago

Stephen P. Ackland, Gavin Marx, C. R. Lewis, John A. Levi, and K Hall. 2002. “Phase I Study of Docetaxel plus Ifosfamide in Patients with Advanced Cancer.” British Journal of Cancer 87 (8). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....05aef2b51d5f33a94acc3f3228290c0e&authtype=sso&custid=ns315887.